BLOG

May 19, 20211 min read

Sandoz runs into legal dead end for biosimilar Etanercept (Enbrel)

The U.S. Supreme Court denied taking up Sandoz's petition for it to review earlier decisions that had favored Amgen in the long-running...

For more details contact us via

Phone, E-mail or Linkedin